annual CAPEX:
$485.40M+$227.00M(+87.85%)Summary
- As of today (April 25, 2025), VRTX annual capital expenditures is $485.40 million, with the most recent change of +$227.00 million (+87.85%) on December 31, 2024.
- During the last 3 years, VRTX annual CAPEX has risen by +$250.40 million (+106.55%).
- VRTX annual CAPEX is now at all-time high.
Performance
VRTX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$92.60M+$24.90M(+36.78%)Summary
- As of today (April 25, 2025), VRTX quarterly capital expenditures is $92.60 million, with the most recent change of +$24.90 million (+36.78%) on December 31, 2024.
- Over the past year, VRTX quarterly CAPEX has dropped by -$23.50 million (-20.24%).
- VRTX quarterly CAPEX is now -62.72% below its all-time high of $248.40 million, reached on March 31, 2024.
Performance
VRTX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$485.40M-$23.50M(-4.62%)Summary
- As of today (April 25, 2025), VRTX TTM capital expenditures is $485.40 million, with the most recent change of -$23.50 million (-4.62%) on December 31, 2024.
- Over the past year, VRTX TTM CAPEX has increased by +$227.00 million (+87.85%).
- VRTX TTM CAPEX is now -4.62% below its all-time high of $508.90 million, reached on September 30, 2024.
Performance
VRTX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VRTX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.8% | -20.2% | +87.8% |
| 3 y3 years | +106.5% | +70.8% | +108.4% |
| 5 y5 years | +543.8% | +70.8% | +108.4% |
VRTX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.1% | -62.7% | +175.6% | -4.6% | +175.9% |
| 5 y | 5-year | at high | +543.8% | -62.7% | +418.4% | -4.6% | +532.0% |
| alltime | all time | at high | >+9999.0% | -62.7% | +282.8% | -4.6% | +2656.3% |
Vertex Pharmaceuticals Incorporated CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $485.40M(+87.8%) | $92.60M(+36.8%) | $485.40M(-4.6%) |
| Sep 2024 | - | $67.70M(-11.7%) | $508.90M(+5.6%) |
| Jun 2024 | - | $76.70M(-69.1%) | $481.80M(+3.7%) |
| Mar 2024 | - | $248.40M(+114.0%) | $464.70M(+79.8%) |
| Dec 2023 | $258.40M(+26.2%) | $116.10M(+186.0%) | $258.40M(+46.9%) |
| Sep 2023 | - | $40.60M(-31.9%) | $175.90M(-7.2%) |
| Jun 2023 | - | $59.60M(+41.6%) | $189.50M(+3.4%) |
| Mar 2023 | - | $42.10M(+25.3%) | $183.20M(-10.5%) |
| Dec 2022 | $204.70M(-12.9%) | $33.60M(-38.0%) | $204.70M(-12.1%) |
| Sep 2022 | - | $54.20M(+1.7%) | $232.90M(+0.8%) |
| Jun 2022 | - | $53.30M(-16.2%) | $231.10M(+1.5%) |
| Mar 2022 | - | $63.60M(+2.9%) | $227.70M(-3.1%) |
| Dec 2021 | $235.00M(-9.5%) | $61.80M(+17.9%) | $235.00M(+6.4%) |
| Sep 2021 | - | $52.40M(+5.0%) | $220.89M(-35.7%) |
| Jun 2021 | - | $49.90M(-29.6%) | $343.29M(+10.3%) |
| Mar 2021 | - | $70.90M(+48.7%) | $311.25M(+19.8%) |
| Dec 2020 | $259.80M(+244.6%) | $47.69M(-72.7%) | $259.80M(+13.5%) |
| Sep 2020 | - | $174.79M(+878.5%) | $228.82M(+192.2%) |
| Jun 2020 | - | $17.86M(-8.2%) | $78.31M(+2.0%) |
| Mar 2020 | - | $19.45M(+16.4%) | $76.81M(+1.9%) |
| Dec 2019 | $75.40M(-21.0%) | $16.71M(-31.2%) | $75.40M(+1.4%) |
| Sep 2019 | - | $24.29M(+48.5%) | $74.34M(+4.8%) |
| Jun 2019 | - | $16.36M(-9.3%) | $70.96M(-15.7%) |
| Mar 2019 | - | $18.04M(+15.3%) | $84.21M(-11.8%) |
| Dec 2018 | $95.45M(-63.2%) | $15.65M(-25.2%) | $95.45M(-22.3%) |
| Sep 2018 | - | $20.91M(-29.4%) | $122.79M(-57.6%) |
| Jun 2018 | - | $29.61M(+1.1%) | $289.83M(+4.4%) |
| Mar 2018 | - | $29.28M(-31.9%) | $277.60M(+7.0%) |
| Dec 2017 | $259.42M(+358.6%) | $42.98M(-77.1%) | $259.42M(+12.2%) |
| Sep 2017 | - | $187.96M(+981.6%) | $231.22M(+304.6%) |
| Jun 2017 | - | $17.38M(+56.6%) | $57.15M(+2.6%) |
| Mar 2017 | - | $11.10M(-24.9%) | $55.69M(-1.5%) |
| Dec 2016 | $56.56M(+24.9%) | $14.79M(+6.5%) | $56.56M(+4.2%) |
| Sep 2016 | - | $13.88M(-12.8%) | $54.30M(+10.3%) |
| Jun 2016 | - | $15.92M(+32.9%) | $49.22M(+5.3%) |
| Mar 2016 | - | $11.97M(-4.4%) | $46.72M(+3.1%) |
| Dec 2015 | $45.30M(-11.5%) | $12.53M(+42.4%) | $45.30M(-4.5%) |
| Sep 2015 | - | $8.80M(-34.4%) | $47.45M(-1.0%) |
| Jun 2015 | - | $13.42M(+27.1%) | $47.95M(+3.7%) |
| Mar 2015 | - | $10.56M(-28.1%) | $46.23M(-9.7%) |
| Dec 2014 | $51.20M(-0.4%) | $14.68M(+57.8%) | $51.20M(+0.4%) |
| Sep 2014 | - | $9.30M(-20.5%) | $51.00M(-15.3%) |
| Jun 2014 | - | $11.70M(-24.6%) | $60.21M(+19.7%) |
| Mar 2014 | - | $15.53M(+7.3%) | $50.31M(-2.1%) |
| Dec 2013 | $51.39M(-27.8%) | $14.47M(-21.8%) | $51.39M(-20.9%) |
| Sep 2013 | - | $18.51M(+928.0%) | $64.97M(-4.2%) |
| Jun 2013 | - | $1.80M(-89.2%) | $67.85M(-16.8%) |
| Mar 2013 | - | $16.61M(-40.8%) | $81.59M(+14.7%) |
| Dec 2012 | $71.14M(+105.6%) | $28.05M(+31.1%) | $71.14M(-1038.9%) |
| Sep 2012 | - | $21.40M(+37.7%) | -$7.58M(-60.1%) |
| Jun 2012 | - | $15.54M(+152.5%) | -$18.99M(-152.9%) |
| Mar 2012 | - | $6.16M(-112.1%) | $35.90M(+3.8%) |
| Dec 2011 | $34.59M(-9.1%) | -$50.67M(-607.5%) | $34.59M(-65.3%) |
| Sep 2011 | - | $9.98M(-85.8%) | $99.69M(-0.8%) |
| Jun 2011 | - | $70.43M(+1352.2%) | $100.54M(+152.6%) |
| Mar 2011 | - | $4.85M(-66.4%) | $39.79M(+4.6%) |
| Dec 2010 | $38.05M(+62.0%) | $14.43M(+33.2%) | $38.05M(+22.0%) |
| Sep 2010 | - | $10.83M(+11.8%) | $31.20M(+24.2%) |
| Jun 2010 | - | $9.69M(+211.4%) | $25.13M(+25.5%) |
| Mar 2010 | - | $3.11M(-59.0%) | $20.03M(-14.8%) |
| Dec 2009 | $23.50M(-27.0%) | $7.58M(+59.4%) | $23.50M(+4.3%) |
| Sep 2009 | - | $4.75M(+3.6%) | $22.53M(-20.3%) |
| Jun 2009 | - | $4.59M(-30.3%) | $28.28M(-15.0%) |
| Mar 2009 | - | $6.58M(-0.5%) | $33.27M(+3.4%) |
| Dec 2008 | $32.18M | $6.61M(-37.1%) | $32.18M(+4.6%) |
| Sep 2008 | - | $10.51M(+9.8%) | $30.77M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $9.57M(+74.2%) | $28.19M(-11.3%) |
| Mar 2008 | - | $5.49M(+5.7%) | $31.78M(-2.0%) |
| Dec 2007 | $32.41M(-0.0%) | $5.20M(-34.4%) | $32.41M(-5.8%) |
| Sep 2007 | - | $7.93M(-39.7%) | $34.40M(+2.8%) |
| Jun 2007 | - | $13.15M(+114.5%) | $33.47M(+7.6%) |
| Mar 2007 | - | $6.13M(-14.7%) | $31.10M(-4.1%) |
| Dec 2006 | $32.42M(+91.1%) | $7.19M(+2.7%) | $32.42M(+6.7%) |
| Sep 2006 | - | $7.00M(-35.1%) | $30.37M(+9.2%) |
| Jun 2006 | - | $10.78M(+44.6%) | $27.81M(+31.3%) |
| Mar 2006 | - | $7.45M(+44.9%) | $21.17M(+24.8%) |
| Dec 2005 | $16.96M(+35.7%) | $5.14M(+16.0%) | $16.96M(+8.6%) |
| Sep 2005 | - | $4.43M(+7.0%) | $15.62M(+20.0%) |
| Jun 2005 | - | $4.14M(+27.9%) | $13.02M(+1.2%) |
| Mar 2005 | - | $3.24M(-14.9%) | $12.86M(+2.9%) |
| Dec 2004 | $12.49M(-28.0%) | $3.80M(+107.8%) | $12.49M(-2.5%) |
| Sep 2004 | - | $1.83M(-54.0%) | $12.81M(+37.3%) |
| Jun 2004 | - | $3.98M(+38.5%) | $9.33M(-29.8%) |
| Mar 2004 | - | $2.88M(-30.2%) | $13.29M(-23.4%) |
| Dec 2003 | $17.35M(-55.4%) | $4.12M(-349.5%) | $17.35M(-19.1%) |
| Sep 2003 | - | -$1.65M(-120.8%) | $21.45M(-39.6%) |
| Jun 2003 | - | $7.94M(+14.5%) | $35.50M(-1.4%) |
| Mar 2003 | - | $6.94M(-15.6%) | $36.00M(-7.4%) |
| Dec 2002 | $38.88M(-27.9%) | $8.22M(-33.7%) | $38.88M(-8.3%) |
| Sep 2002 | - | $12.40M(+46.8%) | $42.38M(-18.4%) |
| Jun 2002 | - | $8.45M(-13.9%) | $51.95M(-3.2%) |
| Mar 2002 | - | $9.81M(-16.3%) | $53.66M(-0.4%) |
| Dec 2001 | $53.90M(+198.9%) | $11.73M(-46.6%) | $53.90M(-0.4%) |
| Sep 2001 | - | $21.97M(+116.3%) | $54.10M(+60.0%) |
| Jun 2001 | - | $10.16M(+1.1%) | $33.80M(+33.0%) |
| Mar 2001 | - | $10.05M(-15.8%) | $25.43M(+41.0%) |
| Dec 2000 | $18.03M(+11.3%) | $11.93M(+614.4%) | $18.03M(+104.9%) |
| Sep 2000 | - | $1.67M(-6.1%) | $8.80M(-31.2%) |
| Jun 2000 | - | $1.78M(-33.0%) | $12.80M(-21.7%) |
| Mar 2000 | - | $2.65M(-1.7%) | $16.35M(+1.0%) |
| Dec 1999 | $16.20M(+105.1%) | $2.70M(-52.4%) | $16.20M(+3.2%) |
| Sep 1999 | - | $5.67M(+6.3%) | $15.70M(+39.8%) |
| Jun 1999 | - | $5.33M(+113.2%) | $11.23M(+37.0%) |
| Mar 1999 | - | $2.50M(+13.6%) | $8.20M(+3.8%) |
| Dec 1998 | $7.90M(+31.7%) | $2.20M(+83.3%) | $7.90M(+3.9%) |
| Sep 1998 | - | $1.20M(-47.8%) | $7.60M(+1.3%) |
| Jun 1998 | - | $2.30M(+4.5%) | $7.50M(+27.1%) |
| Mar 1998 | - | $2.20M(+15.8%) | $5.90M(-1.7%) |
| Dec 1997 | $6.00M(+50.0%) | $1.90M(+72.7%) | $6.00M(-6.3%) |
| Sep 1997 | - | $1.10M(+57.1%) | $6.40M(+8.5%) |
| Jun 1997 | - | $700.00K(-69.6%) | $5.90M(+3.5%) |
| Mar 1997 | - | $2.30M(0.0%) | $5.70M(+42.5%) |
| Dec 1996 | $4.00M(-25.9%) | $2.30M(+283.3%) | $4.00M(-25.9%) |
| Sep 1996 | - | $600.00K(+20.0%) | $5.40M(-1.8%) |
| Jun 1996 | - | $500.00K(-16.7%) | $5.50M(0.0%) |
| Mar 1996 | - | $600.00K(-83.8%) | $5.50M(+1.9%) |
| Dec 1995 | $5.40M(+184.2%) | $3.70M(+428.6%) | $5.40M(+157.1%) |
| Sep 1995 | - | $700.00K(+40.0%) | $2.10M(+23.5%) |
| Jun 1995 | - | $500.00K(0.0%) | $1.70M(+54.5%) |
| Mar 1995 | - | $500.00K(+25.0%) | $1.10M(-42.1%) |
| Dec 1994 | $1.90M(+5.6%) | $400.00K(+33.3%) | $1.90M(+5.6%) |
| Sep 1994 | - | $300.00K(-400.0%) | $1.80M(-5.3%) |
| Jun 1994 | - | -$100.00K(-107.7%) | $1.90M(0.0%) |
| Mar 1994 | - | $1.30M(+333.3%) | $1.90M(+5.6%) |
| Dec 1993 | $1.80M(+20.0%) | $300.00K(-25.0%) | $1.80M(-33.3%) |
| Sep 1993 | - | $400.00K(-500.0%) | $2.70M(+42.1%) |
| Jun 1993 | - | -$100.00K(-108.3%) | $1.90M(+5.6%) |
| Mar 1993 | - | $1.20M(0.0%) | $1.80M(+20.0%) |
| Dec 1992 | $1.50M(+25.0%) | $1.20M(-400.0%) | $1.50M(+400.0%) |
| Sep 1992 | - | -$400.00K(+100.0%) | $300.00K(-57.1%) |
| Jun 1992 | - | -$200.00K(-122.2%) | $700.00K(-22.2%) |
| Mar 1992 | - | $900.00K | $900.00K |
| Dec 1991 | $1.20M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual capital expenditures?
- What is the all time high annual CAPEX for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual CAPEX year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM capital expenditures?
- What is the all time high TTM CAPEX for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM CAPEX year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual capital expenditures?
The current annual CAPEX of VRTX is $485.40M
What is the all time high annual CAPEX for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual capital expenditures is $485.40M
What is Vertex Pharmaceuticals Incorporated annual CAPEX year-on-year change?
Over the past year, VRTX annual capital expenditures has changed by +$227.00M (+87.85%)
What is Vertex Pharmaceuticals Incorporated quarterly capital expenditures?
The current quarterly CAPEX of VRTX is $92.60M
What is the all time high quarterly CAPEX for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly capital expenditures is $248.40M
What is Vertex Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?
Over the past year, VRTX quarterly capital expenditures has changed by -$23.50M (-20.24%)
What is Vertex Pharmaceuticals Incorporated TTM capital expenditures?
The current TTM CAPEX of VRTX is $485.40M
What is the all time high TTM CAPEX for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM capital expenditures is $508.90M
What is Vertex Pharmaceuticals Incorporated TTM CAPEX year-on-year change?
Over the past year, VRTX TTM capital expenditures has changed by +$227.00M (+87.85%)